Announced Mon, 19 Oct, 2026 · 17:55 IST

Board Meeting on Oct 29, 2026 to Approve Q2/Half-Year Results

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹70.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-0.7% vs market

Pharmaceuticals peers, median of 172sector-1.7%-1.7% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3-2.6-0.7-1.7-1.7

Next day

-4.3-3.6-0.7-2.1-2.2

-3.6-5.8+2.3-3.4-0.2

-3.6-5.5+1.8-2.3-1.3

-1.4-3.8+2.4-1.1-0.3

———+0.2—

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Colinz Laboratories has informed BSE that its Board of Directors will meet on Thursday, October 29, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026. The trading window for dealing in the company shares remained closed from October 1, 2026 until 48 hours after the results are communicated to the stock exchange.

Likely market impact

Routine procedural filing. Watch for the Q2 FY27 results announcement on or after October 29, 2026 for actual performance updates.